Daniel, C;Renders, L;Amann, K;Schulze-Lohoff, E;Hauser, IA;Hugo, C
Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.
Am J Transplant
2005
5
12
2849-61

Lutz, J;Yao, Y;Song, E;Antus, B;Hamar, P;Liu, S;Heemann, U
Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats.
Transplantation
2005
79
6
655-61

Vítko, S;Klinger, M;Salmela, K;Wlodarczyk, Z;Tyden, G;Senatorski, G;Ostrowski, M;Fauchald, P;Kokot, F;Stefoni, S;Perner, F;Claesson, K;Castagneto, M;Heemann, U;Carmellini, M;Squifflet, JP;Weber, M;Segoloni, G;Bäckman, L;Sperschneider, H;Krämer, BK
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.
Transplantation
2005
80
12
1734-41

Hamar, P;Liptak, P;Heemann, U;Iványi, B
Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
Transpl Int
2005
18
7
863-70

Margreiter, R;Pohanka, E;Sparacino, V;Sperschneider, H;Kunzendorf, U;Huber, W;Lameire, N;Andreucci, VE;Donati, D;Heemann, U
Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
Transpl Int
2005
18
7
816-23

Antus, B;Liu, S;Yao, Y;Zou, H;Song, E;Lutz, J;Heemann, U
Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.
Nephrol Dial Transplant
2005
20
2
329-35

Baum, H;von Meyer, A;Heemann, U;Hallbach, J
BNP and NT-proBNP in patients with renal failure and haemodialysis
Clin Chim Acta
2005
355 Suppl.
S112-S113

Zohlnhofer, D;Hausleiter, J;Kastrati, A;Mehilli, J;Goos, C;Schuhlen, H;Pache, J;Pogatsa-Murray, G;Heemann, U;Dirschinger, J;Schömig, A
A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.
J Am Coll Cardiol
2005
46
11
1999-2003